IL-21 is elevated in the serum of AD and MCI patients, and blocking IL-21 can alleviate neuroinflammation and Aβ plaques in 5 × FAD mice (Agrawal et al., 2022). The gene discussed is IL21; the disease is Alzheimer disease.